Provectus Biopharmaceuticals Inc (PVCT): Passive position in Provectus Roughl...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Provectus Biopharmaceuticals Inc (PVCT)

Reply Private New

Keep Last Read

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	376
Boards Moderated	0
Alias Born	04/24/2012

Re: None

Thursday, 01/19/2017 7:39:56 PM

Thursday, January 19, 2017 7:39:56 PM

Passive position in Provectus

Roughly a 4% passive stake with upwards of 15% cumulative in near term. Passive today but could readily become an activist tomorrow. Underperforming with valuable assets. This is a pivitol time for Provectus shareholders and the threat of a proxy fight could force the placement on the board of directors. The CEO could then be properly recruited. Provectus is in the quagmire of an activist cross-hairs. Provectus isn't Merck but it should not be trading in a .01-.02 channel either. The equity reasonably should be in a .40-.80 range.

Net across all investments, next week should bare developments towards proper valuation. Hold onto your shares and ride the lightning north.

Keep Last Read

Replies (4) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent PVCT News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:22:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 08:16:08 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 07:12:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 02:30:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 04:12:08 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:54:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:05:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 08:16:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 10:29:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:21:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 07:55:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:56:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 04:39:50 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:07:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 05:49:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 11:51:45 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 10:23:39 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:35:05 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 01:30:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/27/2023 09:55:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 09:16:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 04:04:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 11:07:30 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 05:40:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2023 04:48:55 PM

More PVCT News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow